Status:
UNKNOWN
Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples
Lead Sponsor:
Abbott Molecular
Conditions:
Genetic Disorders
Eligibility:
All Genders
Brief Summary
The objective of this study is to validate the performance characteristics of the GeneTrait CGH Microarray System DX. Reproducibility among sites, lots, and operators will be evaluated.
Eligibility Criteria
Inclusion
- Must be able to donate at least 10 mL of whole blood
- Must be able to provide consent, or parental consent and patient assent (if applicable)
- Must be currently followed as a patient of a genetic clinic or counselor at one of the recruiting sites
- Must have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or fluorescence in situ hybridization (FISH) analysis (within any of the 73 critical regions)
Exclusion
- Unable to donate at least 10 mL of whole blood
- Unable to provide consent, or parental consent and patient assent (if applicable)
- Not currently followed as a patient of a genetic clinic or counselor at one of the recruiting sites
- Does not have at least one chromosomal change that is detectable by the GeneTrait CGH Microarray System DX as determined by karyotype and/or FISH analysis (within any of the 73 critical regions)
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00214448
Last Update
July 14 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.